AB1058

Anti-Influenza B Antibody

Name: Anti-Influenza B Antibody
Brand: MM

Chemicon^®, from goat

Slide 1 of 1

Sign Into View Organizational & Contract Pricing

Select a Size

Pricing and availability is not currently available.

About This Item

UNSPSC Code:

12352203

eCl@ss:

32160702

NACRES:

NA.41

Key Documents

View All Documentation

biological source

goat

Quality Level

300

antibody form

purified antibody

clone

polyclonal

species reactivity

human

manufacturer/tradename

Chemicon^®

technique(s)

ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable

shipped in

wet ice

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item	AB1074	AB1056	AB1129
Sigma-Aldrich AB1058 Anti-Influenza B Antibody	Sigma-Aldrich AB1074 Anti-Influenza A Antibody	Sigma-Aldrich AB1056 Anti-Adenovirus Antibody	Sigma-Aldrich AB1129 Anti-Rotavirus Antibody
species reactivity human	species reactivity human	species reactivity human	species reactivity human
antibody form purified antibody	antibody form purified immunoglobulin	antibody form purified antibody	antibody form purified immunoglobulin
biological source goat	biological source goat	biological source goat	biological source goat
clone polyclonal	clone polyclonal	clone polyclonal	clone polyclonal
shipped in wet ice	shipped in wet ice	shipped in wet ice	shipped in wet ice
technique(s) ELISA: suitable, immunohistochemistry: suitable, immunofluorescence: suitable, western blot: suitable	technique(s) ELISA: suitable, immunofluorescence: suitable, immunohistochemistry: suitable, western blot: suitable	technique(s) ELISA: suitable, immunofluorescence: suitable, immunohistochemistry: suitable, western blot: suitable	technique(s) ELISA: suitable, immunofluorescence: suitable, immunohistochemistry: suitable, western blot: suitable

Immunogen

Yamagata strain of Influenza B

Application

Detect Influenza B using this Anti-Influenza B Antibody validated for use in ELISA, IF, WB, IH.

ELISA

Fluorescence microscopy

Immunoblotting; unboiled samples in 1mM DTT and 2% SDS only.

Immunohistochemistry.

IFA: >1:1,000.

Optimal working dilutions must be determined by end user.

Research Category
Infectious Diseases

Research Sub Category
Infectious Diseases - Viral

Biochem/physiol Actions

Influenza B, purified virions. Non reactive with monkey kidney cells.

No cross-reactivity with Influenza A virus, Parainfluenza virus (types 1-3), RSV or Adenovirus.

Physical form

Format: Purified

IgG fraction. Liquid in PBS (0.01 M, pH 7.2) and 0.1% sodium azide. >95% pure.

Preparation Note

Maintain at +2-8°C for 3 months or at -20°C in aliquots for up to 12 months. Avoid repeated freeze/thaw cycles. Store under subdued light.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Brevican distinctively assembles extracellular components at the large diameter nodes of Ranvier in the CNS.

Yoko Bekku,Uwe Rauch,Yoshifumi Ninomiya,Toshitaka Oohashi

Journal of Neurochemistry null

A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitis.

Donald Y M Leung et al.

The Journal of allergy and clinical immunology, 139(5), 1575-1582 (2017-02-18)

Antibody responses to the inactivated seasonal influenza vaccine in patients with atopic dermatitis (AD) have not been carefully characterized. The primary objective of this study was to compare antibody responses to intradermal vaccination in participants with moderate/severe AD with those

Bral1: its role in diffusion barrier formation and conduction velocity in the CNS.

Bekku, Y; Vargova, L; Goto, Y; Vorisek, I; Dmytrenko, L; Narasaki, M; Ohtsuka, A; Fassler et al.

The Journal of Neuroscience null

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service